Filing Flows › Tvardi Therapeutics (TVRD) › How it makes money
How Tvardi Therapeutics (TVRD) makes money
Tvardi Therapeutics (TVRD) made $2.6M of revenue in the first quarter 2025 (Q1 2025), +72% from a year earlier. Other revenue brought in $1.3M (51%); Collaborative revenue brought in $1.2M (47%); Clinical compound revenue brought in $48K (2%).
Drawing the Sankey…
Revenue by segment, Q1 2025
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Other revenue | $1.3M | 51.5% | — | +112% |
| Collaborative revenue | $1.2M | 46.6% | — | +52% |
| Clinical compound revenue | $48K | 1.9% | — | -43% |
Where each dollar of revenue goes
| Line | Q1 2025 | % of revenue |
|---|---|---|
| Revenue | $2.6M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q1 2025 | $2.6M | +20% |
| Q4 2024 | $1.5M | -52% |
From Tvardi Therapeutics' 10-Q filed May 13, 2025 (on EDGAR).
Questions
How does Tvardi Therapeutics make money?
Tvardi Therapeutics (TVRD) made $2.6M of revenue in the first quarter 2025 (Q1 2025), +72% from a year earlier. Other revenue brought in $1.3M (51%); Collaborative revenue brought in $1.2M (47%); Clinical compound revenue brought in $48K (2%).
What is Tvardi Therapeutics' biggest business?
Other revenue: $1.3M in the first quarter 2025, 51% of revenue, +112% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.